Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-12-19Clinical Trial Update: Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation [Phase 3]
Phase 3 trial evaluating the efficacy and safety of dianicline versus placebo as an aid to smoking cessation has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers [Phase 1]
Pfizer reports completion of a Phase 1 pharmacokinetic study evaluating multiple-dose varenicline in healthy adolescent smokers to character…
-
CLINICAL_TRIALS trial_result · 2008-10-24Clinical Trial Update: ROSCAP: Reduction of Smoking in Cardiac Patients Study [NA]
The ROSCAP trial investigating reduction of smoking in cardiac patients has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-26Clinical Trial Update: Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness
Three-year follow-up results from a randomized controlled trial of an intervention for tobacco dependence in individuals with a psychotic il…
-
CLINICAL_TRIALS trial_result · 2008-07-04Clinical Trial Update: A Brain Imaging Study of Nicotine Release in Cigarette Smokers
A brain imaging study evaluating nicotine release in cigarette smokers sponsored by Hadassah Medical Organization has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes [Phase 2]
Phase 2 clinical trial evaluating EVT 302 with or without nicotine replacement therapy on craving and withdrawal in healthy male smokers dep…
-
CLINICAL_TRIALS trial_result · 2008-05-23Clinical Trial Update: Bupropion for Hospital-Based Smoking Cessation [Phase 3]
A Phase 3 trial evaluating bupropion for hospital-based smoking cessation has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in Smokers [NA]
A completed clinical trial investigated how craving and abstinence from cigarettes influence brain metabolism in smokers. The study was spon…
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Adjustment of DOses of NIcotine in Smoking Cessation (ADONIS) [Phase 4]
Phase 4 clinical trial updating nicotine dosing for smoking cessation (ADONIS) has completed. The study examined dosing strategies for nicot…
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking [Phase 1]
Phase 1 trial evaluated AFQ056 in combination with nicotine for reducing cigarette smoking; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2007-06-11Clinical Trial Update: Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation [Phase 4]
A Phase 4 randomized trial compares ultrashort psychotherapy to sustained-release bupropion for smoking cessation; study status is completed…
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: 12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation. [Phase 2]
Pfizer reports Phase 2 results evaluating four dosing regimens of CP-526,555 versus placebo for smoking cessation over 12 weeks, focusing on…
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: 12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation [Phase 2]
A Phase 2 trial from Pfizer evaluated the safety and efficacy of three doses of CP-526,555 versus placebo for smoking cessation over 12 week…
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: 12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of flexible dosing of CP-526,555 versus placebo for smoking cessation over 12 weeks.
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation [Phase 3]
Phase 3 study evaluating the safety and efficacy of varenicline versus placebo and bupropion (Zyban) for smoking cessation completed over a …
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline [Phase 3]
A completed Phase 3 placebo-controlled trial evaluating the safety of varenicline for smoking cessation over 52 weeks.
-
CLINICAL_TRIALS trial_result · 2007-06-04Clinical Trial Update: An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation [Phase 3]
Pfizer-sponsored Phase 3 open-label trial compares varenicline to a transdermal nicotine patch for smoking cessation and has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-05Clinical Trial Update: The Effect of Smoking on Perception
A clinical trial update from American University studying the effect of smoking on perception in nicotine dependence; the current trial stat…
-
CLINICAL_TRIALS trial_result · 2007-01-31Clinical Trial Update: Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers [NA]
A clinical trial update examining how nicotine affects neurocognitive performance in cigarette smokers; the study status is currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2006-11-17Clinical Trial Update: Family Consultation for Health-Compromised Smokers [Phase 1]
Phase 1 clinical trial update on family consultation for health-compromised smokers related to nicotine dependence; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2006-06-27Clinical Trial Update: Bupropion Treatment for Youth Smoking Cessation [Phase 3]
Phase 3 trial evaluating bupropion for youth smoking cessation has completed.